| Literature DB >> 33324882 |
Rainer Dziewas1, Matthias Auf dem Brinke2, Ulrich Birkmann3, Götz Bräuer4, Kolja Busch5, Franziska Cerra6, Renate Damm-Lunau7, Juliane Dunkel8, Amelie Fellgiebel7, Elisabeth Garms9, Jörg Glahn6, Sandra Hagen10, Sophie Held11, Christine Helfer12, Mirko Hiller13, Christina Horn-Schenk14, Christoph Kley3, Nikolaus Lange15, Sriramya Lapa16, Christian Ledl17, Beate Lindner-Pfleghar18, Marion Mertl-Rötzer17, Madeleine Müller19, Hermann Neugebauer18, Duygu Özsucu12, Michael Ohms20, Markus Perniß21, Waltraud Pfeilschifter16, Tanja Plass9, Christian Roth8, Robin Roukens22, Tobias Schmidt-Wilcke23,24, Beate Schumann25, Julia Schwarze20, Kathi Schweikert19, Holger Stege26, Dirk Theuerkauf2, Randall S Thomas10, Ulrich Vahle14, Nancy Voigt27, Hermann Weber15, Cornelius J Werner28, Rainer Wirth29, Ingo Wittich11, Hartwig Woldag26, Tobias Warnecke1.
Abstract
BACKGROUND: At present, the flexible endoscopic evaluation of swallowing (FEES) is one of the most commonly used methods for the objective assessment of swallowing. This multicenter trial prospectively collected data on the safety of FEES and also assessed the impact of this procedure on clinical dysphagia management.Entities:
Year: 2019 PMID: 33324882 PMCID: PMC7650078 DOI: 10.1186/s42466-019-0021-5
Source DB: PubMed Journal: Neurol Res Pract ISSN: 2524-3489
Epidemiological and clinical characteristics of the patient cohort. Numbers in brackets give the number of patients with complete datasets with regards to the specific items
| General characteristics ( | |
|---|---|
| Age | 69.8 (14.6) |
| Female gender | 1013 (42.2) |
| Barthel | 35 (35.4)) |
| RASS | −0.1 (0.81) |
| Anticoagulation | 451 (18.8) |
| Anti-platelets | 796 (33.2) |
| Antithrombotic drugs | 1005 (41.9) |
| Specific characteristics ( | |
| Complex patients | 1089 (45.4) |
| Respiratory problems | 279 (11.6) |
| Tracheal cannula | 447 (18.6) |
| Agitation | 161 (6.7) |
| Disorientation | 496 (20.7) |
| Fluctuating vigilance | 390 (16.2) |
| Main Diagnosis ( | |
| Stroke | 1465 (61.0) |
| Stroke with Thrombolysis | 393 (26.8) |
| Parkinson’s Disease | 157 (6.5) |
| Critical-Illness Polyneuropathy | 135 (5.6) |
| Motorneuron Disorder | 75 (3.1) |
| Dementia | 64 (2.7) |
| Malignoma | 48 (2.0) |
| Movenent Disorders (other) | 41 (1.7) |
| Enzephalopathia | 37 (1.5) |
| Traumatic Brain Injury | 36 (1.5) |
| Meningitis/Enzephalitis | 36 (1.5) |
| Myasthenia gravis | 35 (1.5) |
| Immune-mediated neuropathy | 34 (1.4) |
| Psychogenic dysphagia | 34 (1.4) |
| Seizure | 33 (1.4) |
| Myopathy | 29 (1.2) |
| Cervical spine surgery | 20 (0.8) |
| Multiple Sclerosis | 18 (0.7) |
| Pneumonia | 13 (0.5) |
| Esophageal diseases | 12 (0.5) |
| Other/Missing | 79 (3.3) |
Features of the clinical context, in which FEES was carried out
| Setting (N = 2401) | |
| Outpatient service | 216 (9.0) |
| Acute care facility | 1692 (70.5) |
| Rehabilitation facility | 493 (20.5) |
| Level of care (for inpatients, | |
| Normal ward | 808 (46.6) |
| Intermediate care unit | 539 (31.1) |
| Intensive care unit | 388 (22.4) |
| Examiner’s profession ( | |
| Physician involved | 1404 (58.8) |
| SLT involved | 2282 (95.5) |
| SLT alone | 985 (41.2) |
| Examiner’s experience (N = 2401) | |
| < 30 FEES | 420 (17.7) |
| 30–200 FEES | 609 (25.6) |
| 201–500 | 389 (16.4) |
| > 500 | 960 (40.4) |
| Examination time (min.) ( | 9.84 (5.89) |
Fig. 1Tolerance, complications and alterations of cardiorespiratory parameters during FEES. a: Patients’ rating of FEES-associated discomfort ranging from none to severe; b: Incidence of complications; c: Incidence of complications in relation to the clinician’s FEES-experience. Numbers below columns give the number of FEES performed during prior training; d: Procedure-related changes of oxygen saturation (SaO2); E: Procedure-related changes of systolic blood pressure (RRsys); F: Procedure-related changes of heart rate (HR)
Fig. 2Correlation of the FEES-based dysphagia score with the Functional Oral Intake Score (FOIS)
Fig. 3Changes of dysphagia management after FEES. a: Detailed changes of FOIS score after FEES. A positive value indicates an upgrade of the FOIS score after FEES, a negative value indicates more restrictive feeding strategy. b: Summary of FOIS changes and management of tracheotomised patients with regards to decannulation